MOTS-c Research Overview

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a short peptide encoded within mitochondrial DNA rather than nuclear DNA. Mitochondria carry their own small genome, and MOTS-c belongs to a small set of peptides described as mitochondrial-derived peptides (MDPs).

Researchers study MOTS-c primarily as a candidate signaling molecule in mitochondrial–nuclear communication: the process by which mitochondria convey information about their state to the cell nucleus.

MOTS-c was described in 2015 by researchers analyzing short open reading frames within the mitochondrial genome, following earlier work on humanin, the first widely recognized mitochondrial-derived peptide.

Its discovery contributed to a broader shift in mitochondrial biology, in which mitochondria are treated not only as energy-producing organelles but as signaling hubs with their own coding output.

A frequently investigated proposed mechanism involves the folate–methionine cycle and the metabolite AICAR, with downstream effects on AMPK (AMP-activated protein kinase), a central cellular energy sensor. This pathway was proposed in the original characterization work and has been examined in subsequent studies.

Other work has examined nuclear translocation: reports that MOTS-c can move into the nucleus under metabolic stress and associate with stress-response transcription factors. This is an area of active investigation rather than settled fact.

Studies have also measured MOTS-c levels in circulation in relation to exercise and age in humans, as observational biomarker research.

Metabolic research — glucose handling and insulin sensitivity measures in rodent models and cell systems.

Mitochondrial biology and mitochondrial–nuclear retrograde signaling.

Cellular stress response research, including nuclear gene regulation under metabolic stress.

Skeletal muscle and exercise physiology, including observational human measurements of circulating MOTS-c.

Aging biology in model organisms.

Mechanistic findings come from cell culture and rodent studies. The frequently cited metabolic results were obtained in mice under defined dietary conditions.

Human involvement in the literature is largely observational: studies measuring circulating MOTS-c concentrations in relation to age, exercise, or metabolic status. Observational association is not evidence of effect.

Controlled human clinical trials administering MOTS-c are not an established part of the published literature, and no human outcome conclusions are supported.

The field is young, and many findings await independent replication.

Assays for measuring endogenous MOTS-c vary in specificity, complicating comparisons between observational studies.

The proposed AMPK-linked mechanism has not been fully resolved, and alternative explanations remain open.

Translation from rodent metabolic models to human physiology is uncertain.

MOTS-c is a mitochondrial DNA-encoded peptide studied as a signal in mitochondrial–nuclear communication.

Metabolic signaling, AMPK-linked pathways, and cellular stress responses are the main investigative themes, in cells and rodents.

Human data is observational, and no controlled clinical evidence supports outcome claims.

This page is provided for scientific and educational purposes only. It summarizes published laboratory research and does not constitute medical advice, does not describe any approved therapy, and does not provide instructions for human use of any kind.

SFVLAB supplies this compound strictly as a research-use-only material for laboratory investigation.